Sponsored Links / Ads


Recent Bladder/Kidney/Testicular News
VIDEO: Dr. Antoni Ribas Discusses PD1 and PD-L1 Targeted Cancer Drugs

Antoni Ribas, M.D. of UCLA's Jonsson Comprehensive Cancer Center is involved in trials testing new cancer drugs targeting the cell surface molecule called PD-L1 and the immune cell receptors PD1.... [via UCLA]

Featured Bladder/Kidney/Testicular Articles

Bladder Cancer Bookstore 
 Bladder Cancer- Including books on bladder cancer treatment, diagnosis, survivorship and support.... [more]

Image-guided ablation for Renal Cell Carcinoma: An Update 
 Radical nephrectomy (removal of the entire kidney along with the tumor) was for many years the standard of care for the treatment of renal cell carcinoma. However, this has changed over the last sever... [more]

Landmark 15-year study of cancer patients shows aggressive personalized therapy improves survival 
  The one-size-fits-all approach traditionally used in kidney cancer treatment should be changed based on the results of the study, the longest to date to analyze kidney cancer patients and their ... [more]

New drug therapy may halt the spread of metastatic kidney cancer  
  NEW YORK, NY - New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in ... [more]

Testicular cancer: Tumor markers under utilized for monitoring disease according to new research 
  March 17, 2008: A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center ... [more]

Diagnosis and Treatment of Bladder Cancer 
 Review article on the treatment of bladder cancer.... [more]

Kidney Cancer: New Standard of Care Recommended for Advanced Kidney Cancer 
 NEW YORK, January 10, 2007 - Newly published results from a randomized, Phase III trial show that the drug sunitinib malate (Sutent®) is more effective than the conventional treatment... [more]

Kidney Cancer: New Drug Combination Shrinks Kidney Cancers 
 By using a new combination of two anticancer drugs, researchers at Duke University Medical Center have dramatically improved response rates of patients with metastatic kidney cancer, which is now gene... [more]


These review articles are the opinions of the authors. Some of the views may be controversial. CancerNews.com™ does not directly endorse the work. We merely present it as part of our service. Please read the disclaimer.

This site is property of Net Ventures, Inc.